Sponsors & Partners

At Paradise Health Research (PHR), we deliver what sponsors and CROs need most: fast, reliable, high-quality enrollment and execution in Metabolic, Respiratory, and Psychiatric trials. Our technology-forward site, strategic partnerships, and unwavering commitment to excellence make us the ideal partner for accelerating your studies while minimizing risk and timelines.

Unparalleled Patient Access & Recruitment Precision

    • Query our CTMS in real time for super-accurate feasibility assessments — delivered in around 24 hours.

    • Leverage our technological capabilities for competitive, precise enrollment projections and site selection confidence.

  • We prioritize speed without compromising quality:

    • 24-hour turnaround on regulatory document packages and initial responses.

    • 48-hour commitment to First Patient In (FPI) once site green-lit. Our streamlined processes get your study up and running faster than most sites.

    • Option for eSource integration with EDC

  • Partnered with a leading CTMS and eSource provider, PHR is 100% electronic from feasibility through study close-out and archiving. This reduces protocol deviations and compliance issues by up to 20%, ensuring cleaner data and fewer queries.

    • Real-time remote, on-site, or hybrid monitoring via our true RBQM (Risk-Based Quality Management) system — the only site in our region with this capability.

    • Flexible remote visit options to accommodate your monitoring preferences and reduce costs/travel.

  • Our clinical staff brings over 40 years of combined experience and full GCP training. For specialized needs, we flexibly access vetted contractors and experts—giving you complete peace of mind on patient safety and data integrity.

    State-of-the-Art Infrastructure & Support Services

    • Fully calibrated, ready-to-use on-site and off-site equipment.

    • Qualified vendors for trial-specific supplies.

    • Service agreements with multiple diagnostic centers, including a local lab offering highly competitive pricing.

  • Dual enrollment disrupts timelines—we proactively educate patients and participants to prevent it. If it occurs, we commit to:

    • Replacing the affected participant.

    • Returning up to 50% of incurred costs.

Access a stable, pre-stratified patient population of over 3,500 patients identified and tracked in our advanced CTMS system by diagnosis, demographics, and other key criteria. Our deep integration with affiliated PCP and mental health clinics ensures consistent, high-quality referrals—reducing enrollment delays and boosting diversity.

PHR is committed to clinical trial excellence—nothing less. We partner to deliver faster enrollment, superior data quality, reduced risk, and reliable results.

Ready to accelerate your next study? Contact us today at info@paradisehealthresearch.com or submit a feasibility request.